end of compounded tirzepatide (GLP-1/GIP) Drugmakers battle pharmacies over compounded

Nausea, constipation, or disproportionate loss of appetite are the most common issues - often caused by the combination of pain medications, reduced mobility, and the GLP-1 effect itself

Cart is provider-gated

For brief exposure (a few hours), returning the vial to the fridge is acceptable

The evidence points to indirect causes: Metabolic shifts Changes in insulin sensitivity Weight loss Alters the hormonal environment that controls the cycle, rather than the drug directly attacking the menstrual system

Sci Rep 6(1):26859 Zota I et al (2024) Stimulating Myelin restoration with BDNF: a promising therapeutic approach for Alzheimers disease

The reconstitution chart provides the math for common vial sizes and target concentrations